Coronary artery disease (CAD) including myocardial infarction (MI) as its complication, is one of the most common heart diseases worldwide and also in Iran, with extremely elevated mortality. CAD is a multifactorial disorder. Twin and family studies at different loci have demonstrated that genetic factors have an important role in the progression of CAD. Many studies have reported a significant association of CDKN2B-AS, also known as ANRIL which is located within the p15, p16, p14 gene cluster at 9p21 locus, with cardiovascular diseases as well as many other diseases like diabetes and cancers. This study investigated two polymorphisms rs10757274 and rs1333042 of CDKN2B-AS gene at 9p21 locus. 205 subjects, comprising 102 controls and 103 CAD patients were genotyped by TaqMan probe real time PCR technique and haplotypes were examined. This study confirmed the association of rs10757274 variants with CAD in Iranian patients (P= 0.003) but genotype and allele distributions of CAD and control groups showed no significant association for the rs1333042. However, frequency of the [G;G] haplotype of these two SNPs was significantly higher in CAD group (P= 0.0002, Odds Ratio = 3.1, 95% CI = 1.7-5.7). Our finding suggests that [G; G] haplotype of rs10757274 and rs1333042 may be considered as a genetic risk factor for susceptibility to CAD in Iranian patients.
From 2007, independent studies using single nucleotide polymorphism (SNP) arrays have shown that chromosome 9p21 is associated with increased risk of CAD and MI (10) (11) (12) (13) . CDKN2B-AS, also known as ANRIL is a long non-coding RNA which is located within the p15/CDKN2B-p16/CDKN2A-p14/ARF gene cluster at 9p21 locus (14) . Multiple alternatively spliced transcript variants have been generated from this gene, and all of them are long non-coding RNAs (15) (16) (17) . Many studies have reported the significant association of CDKN2B-AS with cardiovascular diseases and also many other diseases like diabetes and cancers (17) (18) (19) (20) .
Moreover, CDKN2B-AS is expressed in tissues and cell types that are affected by atherosclerosis (18) and associated with formation of atherosclerotic plaques (21 
Genotyping
Genomic DNA was extracted from venous blood (5ml) using a commercially available kit (Roche, Germany). The quality of the extracted DNAs was analyzed by gel electrophoresis and was confirmed by spectrophotometry (Nanodrop1000, Thermo Fisher Scientific, Wilmington, DE, USA).
Primer-probe sets were designed by ABI (Applied Bio systems, Foster City, CA, USA).
Genotyping for the rs10757274A>G (Assay ID C__26505812_10) and rs1333042A>G(Assay ID C__1754675_10) in ANRIL gene was performed using TaqMan probe real time PCR (LightCycler 96, Roche, Germany).
Statistical Analysis
Statistical analysis of the data was carried out by SPSS, version 18. Normally distributed data were expressed as means± standard deviation (SD) or median and qualitative variables were expressed as n (%). The statistical difference in allelic and genotype frequencies between patients and controls were compared using the chi-square test and P value<0.05 was considered as statistically significant and for haplotype analyzing of the data, SNP Stats software which has online version as well (http:// bioinfo.iconcologia.net/ snpstats) was used.
Results

Clinical characteristics
Detailed information of CAD patients and controls is provided in The distribution of rs10757274 and rs1333042
haplotypes at 9p21 is summarized in Table 3 In the present study, investigation of the rs10757274 showed a significant difference of allele G distribution between patients (61.7%) and controls (46.4%) (P=0.002). Hence, our results were in accordance with previous studies (25) (26) (27) (28) (29) and also a recent study of rs10757274 in SouthWest Iran (30) Moreover, one of the limitations of this study is the sample size which may not be large enough to allow such differences to appear. The other limiting factor of the present study is that it was performed on a small part of Iranian population (North of Iran), because independent studies in Iran showed genetic variability (42).
In conclusion, the association of rs10757274 variants with CAD in Iranian patients (P =0.003)
was confirmed by the present study but genotype and allele distributions of CAD and control groups showed no significant association for the rs1333042 polymorphism.
However, the frequency of [G; G] haplotype of these two SNPs was significantly higher in CAD group (P = 0.0002).
Our finding suggests that [G; G] haplotype of rs10757274 and rs1333042 may be considered as a genetic risk factor for susceptibility to CAD in North Iranian patients. These data are the beginning of a comprehensive association study of 9p21 haplotype polymorphisms with CAD in Iranian population, although consistent association studies in larger sample sizes are necessary to replicate our findings.
